ELV STOCK ANALYSIS

Elevance Health Inc — price, returns and risk statistics

ELVElevance Health Inc

🇺🇸 USA · US · Healthcare · Healthcare Plans

Value itDuel

Price summary

Last Close

417.89 $

Jul 2, 26

Market Cap

92.1 B $

Q1 2026 (TTM)

52-Week Range

269.01 $422.71 $

Return and risk cards

Total Return

%+21.8

Trailing 1-year performance

Volatility

%37.8

Price fluctuation measure

Sharpe Ratio

-0.34

Risk/Return ratio

Sortino Ratio

-0.31

Downside risk/return

Distance to Peak

%-1.1

Difference from 52-week peak

Maximum Drawdown

-%26.5

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+7.9%

3M

+39.5%

6M

+20.4%

YTD

+20.4%

1Y

+21.8%

3Y

-1.2%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
ELV+20.4%Gold-3.2%Silver-10.4%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Elevance Health Inc (ELV) stock price?

ELV last closed at 417.89 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the P/E ratio of ELV?

Elevance Health Inc trades at a trailing-twelve-month P/E of 17.57. See the comparison tables on the Peers tab for the industry context.

What is the market capitalization of Elevance Health Inc?

Elevance Health Inc (ELV) has a market capitalization of approximately 92.1 B $ as of the latest reported period.

Who are the main competitors of ELV?

Key peers of Elevance Health Inc include EssilorLuxottica S. A., Sanofi SA, Merck KGaA, Bayer AG NA, Siemens Healthineers AG. A detailed metric comparison is available on the Peers tab.

Go deeper on ELV

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.